Wellington Management Group
CGON icon

Wellington Management Group’s CG Oncology CGON Stock Holding History

Wellington Management Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378M Sell
5,324,751
-46,481
-0.9% -$3.04M 0.07% 267
2026
Q1 		$364M Sell
5,371,232
-628,558
-10% -$35.6M 0.07% 254
2025
Q4 		$249M Buy
5,999,790
+487,011
+9% +$20.2M 0.04% 331
2025
Q3 		$222M Buy
5,512,779
+3,613,885
+190% +$105M 0.04% 360
2025
Q2 		$49.4M Sell
1,898,894
-226,314
-11% -$5.45M 0.01% 695
2025
Q1 		$52M Buy
2,125,208
+214,738
+11% +$6.04M 0.01% 675
2024
Q4 		$54.8M Buy
1,910,470
+1,400,251
+274% +$47.9M 0.01% 681
2024
Q3 		$19.3M Buy
510,219
+308,852
+153% +$10.8M ﹤0.01% 967
2024
Q2 		$6.36M Buy
201,367
+2,560
+1% +$88.7K ﹤0.01% 1268
2024
Q1 		$8.73M Buy
+198,807
New +$8.12M ﹤0.01% 1179

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's CGON Position: Q2 2026 in Review

Wellington Management Group reduced its CG Oncology (CGON) stake by 0.87% in Q2 2026, selling an estimated $3.04M and leaving 5,324,751 shares worth $378M. The position accounts for 0.07% of the portfolio, ranked #267.

Wellington Management Group first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Wellington Management Group held 5,324,751 shares of CG Oncology worth $378M as of Q2 2026.
  • Wellington Management Group sold 46,481 CG Oncology shares in Q2 2026, an estimated $3.04M.
  • CG Oncology made up 0.07% of Wellington Management Group's portfolio in Q2 2026, its #267 holding.
  • Wellington Management Group first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.